Nanjing, China · Founded 2021 · Privately Held (backing)
Developer and manufacturer of synthetic biotechnology created to provide customers with better products and services. GeneIII is based in Nanjing, China and was founded in 2021. Its last reported valuation was $55.5 million in Jul 2023. It has raised $22.1 million.
Last reported valuation
$55.5M
Oct 2026
Priced at
—
Total raised
$22.1M
Last round
—
Team — not yet on record
No current team members for GeneIII are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of GeneIII with a free account
·Watch GeneIII: the Monday email on marks, rounds and moves
